Bridgewater Associates, the world’s largest hedge fund, made a notable shift in its investment strategy late last year, increasing its stake in electric vehicle (EV) giant Tesla while exiting positions in major companies like Goldman Sachs and Micron Technology.
According to Bridgewater’s latest 13-F filing, the firm purchased $62 million worth of Tesla shares, representing a 0.28% stake in the company during the fourth quarter of 2024. Tesla stock experienced a post-election rally following the U.S. presidential election in November 2024, largely due to CEO Elon Musk’s close relationship with the new administration. By the end of 2024, Tesla’s stock had surged 62%, but 2025 has proven more challenging, with shares already down 12%, amid concerns over slowing sales and Musk’s increasing involvement in other ventures.
Meanwhile, Bridgewater also expanded its position in Moderna, the vaccine manufacturer, acquiring 605,782 shares for a 0.12% stake. At the same time, it completely exited investments in Goldman Sachs and Micron Technology while drastically reducing its holdings in Applied Materials, a semiconductor company. The hedge fund further trimmed its exposure to consumer staples, cutting stakes in CVS Health and Tyson Foods, signaling a strategic shift in its portfolio.
[Full Article ](https://www.marketwatch.com/story/ray-dalios-bridgewater-made-a-new-bet-on-tesla-he-may-have-gotten-a-bargain-176a9926?mod=home-page)